The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis

Patients with rheumatoid arthritis (RA) are at an increased risk of cardiovascular disease (CVD). Treatment with tumor necrosis factor inhibitors improves both joint symptoms associated with RA and also CVD risk. This exploratory analysis of a phase 4 study evaluated changes in metabolic risk factor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Rheumatol
Hauptverfasser: Deodhar, Atul, Bitman, Bojena, Yang, Yue, Collier, David H
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer London 2016
Schlagworte:
Brief Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5118390/
https://ncbi.nlm.nih.gov/pubmed/27704313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-016-3422-7
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge